The long non-coding RNAs (lncRNAs) are emerging as important regulators in cancer progression. Clear cell renal cell carcinoma(ccRCC) is one of the most common urological cancers with poor prognosis. In this study, we examined the functional role of the lncRNA, nuclear enriched abundant transcript 1 (NEAT1) in ccRCC progression.
METHODS:
We performed quantitative real time PCR and western blotting assays to measure mRNA and protein expression levels, respectively. CCK-8 assay, cell invasion and migration assays were used to determine the cell proliferative, cell invasive and migratory ability. Flow cytometric analysis was performed to examine cell apoptosis.
RESULTS:
The expression levels of NEAT1 was up-regulated in ccRCC tissues and up-regulation of NETA1 was positively correlated with tumor size, higher Fuhrman grade, and lymph node metastasis, and also predicts worse 5-year survival rate of patients with ccRCC. NEAT1 knock-down by NEAT siRNAs transfection suppressed cell proliferation and induced cell apoptosis in ccRCC cell lines. In addition, NEAT1 knock-down suppressed cell invasion and migration and inhibited the mRNA and protein expression levels of epithelial-mesenchymal transition-related markers in ccRCC cell lines.
CONCLUSIONS:
In conclusion, NEAT1 may be an important mediator in the regulation of ccRCC progression and predicts the poor prognosis in patients with ccRCC.
LjungbergB., CampbellS.C., ChoiH.Y., JacqminD., LeeJ.E., WeikertS. and KiemeneyL.A., The epidemiology of renal cell carcinoma, Eur Urol60 (2011), 615-21.
2.
PalS.K. and FiglinR.A., Targeted therapies for renal cell carcinoma: Understanding their impact on survival, Target Oncol5 (2010), 131-8.
3.
PortaC. and SzczylikC., Tolerability of first-line therapy for metastatic renal cell carcinoma, Cancer Treat Rev35 (2009), 297-307.
4.
Van PoppelH., BeckerF., CadedduJ.A., GillI.S., JanetschekG., JewettM.A., LagunaM.P., MarbergerM., MontorsiF., PolascikT.J., UkimuraO. and ZhuG., Treatment of localised renal cell carcinoma, Eur Urol60 (2011), 662-72.
5.
YagodaA., Abi-RachedB. and PetrylakD., Chemotherapy for advanced renal-cell carcinoma: 1983-1993, Semin Oncol22 (1995), 42-60.
6.
BartonicekN., MaagJ.L. and DingerM.E., Long noncoding RNAs in cancer: Mechanisms of action and technological advancements, Mol Cancer15 (2016), 43.
7.
BhanA. and MandalS.S., LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer, Biochim Biophys Acta1856 (2015), 151-64.
8.
GutschnerT., HammerleM. and DiederichsS., MALAT1 - a paradigm for long noncoding RNA function in cancer, J Mol Med (Berl)91 (2013), 791-801.
9.
YaoJ., ChenY., WangY., LiuS., YuanX., PanF. and GengP., Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas, Int J Clin Exp Pathol7 (2014), 2758-67.
10.
ZhangH.M., YangF.Q., ChenS.J., CheJ. and ZhengJ.H., Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma, Tumour Biol36 (2015), 2947-55.
11.
WuY., TanC., WengW.W., DengY., ZhangQ.Y., YangX.Q., GanH.L., WangT., ZhangP.P., XuM.D., WangY.Q. and WangC.F., Long non-coding RNA Linc00152 is a positive prognostic factor for and demonstrates malignant biological behavior in clear cell renal cell carcinoma, Am J Cancer Res6 (2016), 285-99.
12.
SouquereS., BeauclairG., HarperF., FoxA. and PierronG., Highly ordered spatial organization of the structural long noncoding NEAT1 RNAs within paraspeckle nuclear bodies, Mol Biol Cell21 (2010), 4020-7.
13.
ChenZ.J., ZhangZ., XieB.B. and ZhangH.Y., Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer, Eur Rev Med Pharmacol Sci20 (2016), 3373-7.
14.
FuJ.W., KongY. and SunX., Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancer, J Cancer Res Clin Oncol142 (2016), 1571-9.
15.
LoP.K., ZhangY., WolfsonB., GernapudiR., YaoY., DuruN. and ZhouQ., Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis, Oncotarget (2016).
16.
SunC., LiS., ZhangF., XiY., WangL., BiY. and LiD., Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway, Oncotarget (2016).
17.
XianGuoC., ZongYaoH., JunZ., SongF., GuangYueL., LiGangZ., KaiPingZ., YangYangZ. and ChaoZhaoL., Promoting progression and clinicopathological significance of NEAT1 over-expression in bladder cancer, Oncotarget (2016).
18.
WuY., LyuH., LiuH., ShiX., SongY. and LiuB., Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer, Sci Rep6 (2016), 31093.
19.
ChakravartyD., SbonerA., NairS.S., GiannopoulouE., LiR., HennigS., MosqueraJ.M., PauwelsJ., ParkK., KossaiM., MacDonaldT.Y., FontugneJ., ErhoN., VergaraI.A., GhadessiM., DavicioniE., JenkinsR.B., PalanisamyN., ChenZ., NakagawaS., HiroseT., BanderN.H., BeltranH., FoxA.H., ElementoO. and RubinM.A., The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer, Nat Commun5 (2014), 5383.
20.
GuoS., ChenW., LuoY., RenF., ZhongT., RongM., DangY., FengZ. and ChenG., Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients, Int J Clin Exp Pathol8 (2015), 5395-402.
21.
WuY., YangL., ZhaoJ., LiC., NieJ., LiuF., ZhuoC., ZhengY., LiB., WangZ. and XuY., Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer, Mol Cancer14 (2015), 191.
22.
XuH., HeL., FengX., KapoorA. and TangD., Specific reduction of fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma, Cancer Invest27 (2009), 836-43.
DiepenbruckM. and ChristoforiG., Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol43 (2016), 7-13.
25.
PeinadoH. and CanoA., New potential therapeutic targets to combat epithelial tumor invasion, Clin Transl Oncol8 (2006), 851-7.
26.
GotzmannJ., MikulaM., EgerA., Schulte-HermannR., FoisnerR., BeugH. and MikulitsW., Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis, Mutat Res566 (2004), 9-20.
27.
HemavathyK., AshrafS.I. and IpY.T., Snail/slug family of repressors: slowly going into the fast lane of development and cancer, Gene257 (2000), 1-12.
28.
LiuY., El-NaggarS., DarlingD.S., HigashiY. and DeanD.C., Zeb1 links epithelial-mesenchymal transition and cellular senescence, Development135 (2008), 579-88.
29.
LuY., LiT., WeiG., LiuL., ChenQ., XuL., ZhangK., ZengD. and LiaoR., The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma, Tumour Biol (2016).
30.
XiongJ., LiuY., JiangL., ZengY. and TangW., High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma, Jpn J Clin Oncol46 (2016), 378-84.
31.
MlcochovaH., MachackovaT., RabienA., RadovaL., FabianP., IlievR., SlabaK., PoprachA., KilicE., StanikM., Redova-LojovaM., SvobodaM., DolezelJ., VyzulaR., JungK. and SlabyO., Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma, Sci Rep6 (2016), 31852.
32.
LiX., WangS., LiZ., LongX., GuoZ., ZhangG., ZuJ., ChenY. and WenL., NEAT1 induces epithelial-mesenchymal transition and 5-FU resistance through the miR-129/ZEB2 axis in breast cancer, FEBS Lett (2016).
33.
LuY., LiT., WeiG., LiuL., ChenQ., XuL., ZhangK., ZengD. and LiaoR., The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma, Tumour Biol37 (2016), 11733-11741.
